A carregar...
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
BACKGROUND: Tocilizumab is an IL-6 receptor-blocking agent proposed for the treatment of severe COVID-19. The aim of this systematic review was to describe the rationale for the use of tocilizumab for the treatment of COVID-19 and to summarize the available evidence regarding its efficacy and safety...
Na minha lista:
| Publicado no: | Pulmonology |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369580/ https://ncbi.nlm.nih.gov/pubmed/32713784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pulmoe.2020.07.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|